GIP reduces osteoclast activity and improves osteoblast survival in primary human bone cells. (2023)
Attributed to:
Centre for Musculoskeletal Ageing Research
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ejendo/lvac004
PubMed Identifier: 36747334
Publication URI: http://europepmc.org/abstract/MED/36747334
Type: Journal Article/Review
Volume: 188
Parent Publication: European journal of endocrinology
Issue: 1
ISSN: 0804-4643